Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials

Vaccines are needed to disrupt or prevent continued outbreaks of filoviruses in humans across Western and Central Africa, including outbreaks of Marburg virus (MARV). As part of a filovirus vaccine product development plan, it is important to investigate dose response early in preclinical developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Christopher L., Morrow, Gavin, Yuan, Maoli, Coleman, John W., Hou, Fuxiang, Reiserova, Lucia, Li, Shui L., Wagner, Denise, Carpov, Alexei, Wallace-Selman, Olivia, Valentin, Kristie, Choi, Yesle, Wilson, Aaron, Kilianski, Andrew, Sayeed, Eddy, Agans, Krystle N., Borisevich, Viktoriya, Cross, Robert W., Geisbert, Thomas W., Feinberg, Mark B., Gupta, Swati B., Parks, Christopher L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610558/
https://www.ncbi.nlm.nih.gov/pubmed/36298451
http://dx.doi.org/10.3390/vaccines10101582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610558/
https://www.ncbi.nlm.nih.gov/pubmed/36298451
http://dx.doi.org/10.3390/vaccines10101582

Ejemplares similares